Angiopathy in rheumatoid arthritis
Journal Title: Біль. Суглоби. Хребет - Year 2017, Vol 7, Issue 2
Abstract
Background. Among all rheumatologic diseases, rheumatoid arthritis (RA) accounts for 3 % of cases, and the number of such patients is increasing. RA is characterized by systemic vascular lesion (angiopathy), it is determined by the international Chapel Hill classification as “vasculitis associated with systemic disease”. The purpose of the study was to improve the quality of diagnosis, to stablish new links in the pathogenesis and to identify the prognostic criteria for the clinical course of vascular disease in RA. Materials and methods. 131 patients were examined. The ratio of men and women was 1 : 2, the mild, moderate and high degree of the disease activity was 1 : 2 : 1, respectively, the average age of the examined patients was 45.70 ± 1.02 years, the duration of the clinical manifestation was 9.40 ± 0.68 years, I, II, III and IV stages were diagnosed in 8, 40, 34 and 19 % of patients. Echocardiography, sonography and ultrasonic dopplerography of vessels, conjunctival biomicroscopy, morphological examination of kidney biopsy were preformed, integrated indices of clinical and instrumental vascular pathology were determined. Results. Systemic angiopathy is observed in 61 % of patients with RA, more often in cases of high activity with the presence of osteoporosis, the development of skin vasculitis and peripheral vasoneuropathy are closely related to the serum levels of cyclic citrullinated peptide antibodies, which, along with the concentration of C-reactive protein, has a negative prognostic significance for the vascular pathology, and the appearance of digital arteritis is determined by the activity of the joint syndrome, the appearance of glomerulonephritis — by the high content in the blood of circulating immune complexes, and angiopathy presence reflects the pressure increase in the lesser (pulmonary) circulation. Conclusions. In patients with RA, mesangial proliferative and mesangial capillary glomerulonephritis develops in a ratio of 2 : 1, with an appropriate tubulointerstitial component and the immunoglobulins and complement components deposition (in the stroma > glomeruli > tubules > vessels), at that the structural changes in the renal vessels are closely associated with clinical instrumental manifestations of systemic rheumatoid angiopathy. C-reactive protein values in the blood more than 25 mg/L and anti-citrulline antibodies more than 40 U/ml are prognostic negative criteria for systemic vascular pathology and the kidney stroma damage, severe changes in renal tubules are a risk factor for the high rates of the joint syndrome progression.
Authors and Affiliations
O. V. Syniachenko, Ye. D. Iegudina, O. O. Khanyukov, M. V. Iermolaeva
Keywords
Related Articles
- EP ID EP218236
- DOI 10.22141/2224-1507.7.2.2017.108698
- Views 91
- Downloads 0
Information Support of Evidence-Based Health Care. Part I
The article deals with the role of information component of evidence-based health care, the main approaches and techniques of search for evidence in computer databases of evidence-based medicine, the principles of system...
Information letter. On innovations in the health care system. Method for assessing the risk of osteoporosis and its complications at the primary level of medical care
.
Rheological Properties of Blood Serum in Metabolic Syndrome in Patients with Osteoarthritis
Integral rheological properties of the blood serum in patients with osteoarthritis depend on the presence of all components of the metabolic syndrome (primarily on the parameters of insulinemia, the severity of insulin r...
MRI Morphometry of Vertebral Bodies and Intervertebral Discs of the Lumbar Spine in Patients with Bone Mineral Density Disorders
The objective of the investigation — to study the changes of the vertebral bodies, intervertebral discs and their area in the lumbar spine in the reduction of bone mineral density (BMD) using magnetic resonance imaging (...
Abstracts of the III International symposium “Diseases of the bones and joints and the age” (March 12–14, 2018, Lviv, Ukraine)
.